Human tumour necrosis factors-alpha and -beta: differences in their structure, expression and biological properties
- PMID: 2285517
- DOI: 10.1111/j.1574-6968.1990.tb03519.x
Human tumour necrosis factors-alpha and -beta: differences in their structure, expression and biological properties
Abstract
Tumour necrosis factor-alpha (TNF-alpha) and lymphotoxin (LT or TNF-beta) are cytokines, best known for their cytotoxic or cytostatic effects on some tumour cells. They are structurally related, compete for a common receptor, and are potent inducers of similar biological responses. TNF-alpha and LT appear to have distinct three-dimensional structures because they differ greatly in their sensitivity to various proteases and chemical agents, and antibodies raised against one cytokine do not cross-react with the other cytokine. The closely linked TNF-alpha and LT genes are independently regulated since many cell types produce only TNF-alpha or LT. Expression of the TNF-alpha gene can be controlled either at the transcriptional or at the post-transcriptional level. In some cell types, TNF-alpha and LT induce qualitatively or quantitatively different biological responses, and LT can antagonize the action of TNF-alpha. The disparate biological activities of TNF-alpha and LT may be related to their different interactions with a common receptor. It is possible that TNF-alpha and LT have different physiological roles.
Similar articles
-
[Function, molecular structure and gene expression regulation of tumor necrosis factor and lymphotoxin].Nihon Rinsho. 1992 Aug;50(8):1939-44. Nihon Rinsho. 1992. PMID: 1331566 Review. Japanese.
-
Characterization of the receptor for tumor necrosis factor (TNF) and lymphotoxin (LT) on human T lymphocytes. TNF and LT differ in their receptor binding properties and the induction of MHC class I proteins on a human CD4+ T cell hybridoma.J Immunol. 1990 Apr 1;144(7):2582-91. J Immunol. 1990. PMID: 1969453
-
Functional discrepancies between tumor necrosis factor and lymphotoxin alpha explained by trimer stability and distinct receptor interactions.Eur J Immunol. 1995 Aug;25(8):2183-9. doi: 10.1002/eji.1830250810. Eur J Immunol. 1995. PMID: 7664782
-
Woodchuck lymphotoxin-alpha, -beta and tumor necrosis factor genes: structure, characterization and biological activity.Gene. 2000 Jan 25;242(1-2):295-305. doi: 10.1016/s0378-1119(99)00494-1. Gene. 2000. PMID: 10721723
-
Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor system.Eur Cytokine Netw. 1995 Mar-Apr;6(2):83-96. Eur Cytokine Netw. 1995. PMID: 7578992 Review.
Cited by
-
Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis.J Clin Invest. 1994 Aug;94(2):749-60. doi: 10.1172/JCI117394. J Clin Invest. 1994. PMID: 8040330 Free PMC article.
-
Bile mediates intestinal pathology in endotoxemia in rats.Infect Immun. 2000 Aug;68(8):4714-9. doi: 10.1128/IAI.68.8.4714-4719.2000. Infect Immun. 2000. PMID: 10899877 Free PMC article.
-
The role of tumor necrosis factor receptors in cell signaling and the significance of soluble form levels in the serum.Surg Today. 1994;24(3):197-202. doi: 10.1007/BF02032887. Surg Today. 1994. PMID: 8003860 Review.
-
Variation in the lymphotoxin-alpha/tumor necrosis factor locus modifies risk of erythema nodosum in sarcoidosis.J Invest Dermatol. 2009 Aug;129(8):1921-6. doi: 10.1038/jid.2008.456. Epub 2009 Feb 19. J Invest Dermatol. 2009. PMID: 19225544 Free PMC article.